821 related articles for article (PubMed ID: 32480373)
1. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
2. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.
Takiguchi T; Koide H; Nagano H; Nakayama A; Fujimoto M; Tamura A; Komai E; Shiga A; Kono T; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Miyabayashi Y; Ishiwatari N; Horiguchi K; Nakatani Y; Yokote K; Tanaka T
BMC Endocr Disord; 2017 Sep; 17(1):54. PubMed ID: 28865461
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
4. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone.
Oki K; Yamane K; Oda Y; Kamei N; Watanabe H; Tominaga A; Amatya VJ; Oki Y; Kohno N
J Neurosurg; 2009 Feb; 110(2):369-73. PubMed ID: 18991502
[TBL] [Abstract][Full Text] [Related]
5. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
[TBL] [Abstract][Full Text] [Related]
6. A multihormonal pituitary adenoma with growth hormone and adrenocorticotropic hormone production, causing acromegaly and Cushing disease.
Kageyama K; Nigawara T; Kamata Y; Terui K; Anzai J; Sakihara S; Suda T
Am J Med Sci; 2002 Dec; 324(6):326-30. PubMed ID: 12495300
[TBL] [Abstract][Full Text] [Related]
7. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
Saeger W; Koch A
Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
9. The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm.
McDonald WC; McDonald KN; Helmer JA; Ho B; Wang A; Banerji N
Arch Pathol Lab Med; 2021 May; 145(5):592-598. PubMed ID: 32991684
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of tissue-based ACTH-antibody assay-guided transsphenoidal resection of pituitary adenomas in Cushing disease.
Erfe JM; Perry A; McClaskey J; Inzucchi SE; James WS; Eid T; Bronen RA; Mahajan A; Huttner A; Santos F; Spencer D
J Neurosurg; 2018 Sep; 129(3):629-641. PubMed ID: 29027854
[TBL] [Abstract][Full Text] [Related]
11. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
Roca E; Mattogno PP; Porcelli T; Poliani L; Belotti F; Schreiber A; Maffezzoni F; Fontanella MM; Doglietto F
World Neurosurg; 2018 Jun; 114():e158-e164. PubMed ID: 29501516
[TBL] [Abstract][Full Text] [Related]
12. Clinical Parameters of Silent Corticotroph Adenomas With Positive and Negative Adrenocorticotropic Hormone Immunostaining: A Large Retrospective Single-Center Study of 105 Cases.
Zhang K; Shou X; Chen H; Qiao N; He W; Chen Z; Shen M; Li S; Zhao Y; Zhang Z; Li Y; Ye H; Wang Y
Front Endocrinol (Lausanne); 2020; 11():608691. PubMed ID: 33584540
[TBL] [Abstract][Full Text] [Related]
13. A Case of acromegaly associated with subclinical Cushing's disease.
Tsuchiya K; Ohta K; Yoshimoto T; Doi M; Izumiyama H; Hirata Y
Endocr J; 2006 Oct; 53(5):679-85. PubMed ID: 16926523
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
15. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
16. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
19. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
[TBL] [Abstract][Full Text] [Related]
20. 'Silent' somatotropinoma.
Pawlikowski M; Kuta J; Fuss-Chmielewska J; Winczyk K
Endokrynol Pol; 2012; 63(2):88-91. PubMed ID: 22538745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]